Dubovsky Filip
- SEC CIK
- 0001977361
No open-market purchases or sales filed in the past year.
Current role at each company
- NVAX Novavax IncPresident, R&Das of Jun 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Dubovsky Filip as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 (view filing) | Jun 17 | 3 days | Dubovsky FilipPresident, R&D | SSale | −13.9K | $14.47 | −$201.2K | −17.3%66.6K after | 2 lots |
| May 15, 2024 (view filing) | May 14 | 1 day | Dubovsky FilipPresident, R&D | SSale | −47.3K | $13.90 | −$657.6K | −54.8%39.0K after |